Skip to main content

Inhibitor Therapeutics, Inc. (INTI)

OTCMKTS: INTI · Delayed Price · USD
0.1221 0.0001 (0.08%)
Sep 16, 2021 12:17 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017201620152014201320122011
Selling, General & Admin
0.871.541.932.894.382.271.510.820.560.98
Research & Development
0.191.212.632.232.641.682.431.0700
Other Operating Expenses
00000000.1200
Operating Expenses
1.062.754.565.127.023.953.9420.560.98
Operating Income
-1.06-2.75-4.56-5.12-7.02-3.95-3.94-2-0.56-0.98
Interest Expense / Income
0000000.04000.22
Other Expense / Income
-0-0.01-0.01-0.02-0.0200-0.17-0.75-0.97
Pretax Income
-1.06-2.73-4.55-5.1-7-3.95-3.98-1.840.19-0.23
Net Income
-1.06-2.73-4.55-5.1-7-3.95-3.98-1.840.19-0.23
Preferred Dividends
0.20.20.160000000
Net Income Common
-1.26-2.93-4.71-5.1-7-3.95-3.98-1.840.19-0.23
Shares Outstanding (Basic)
37237037036728923396181413
Shares Outstanding (Diluted)
372370370367289233961814-
Shares Change
0.40%0.17%0.87%26.97%24.13%142.60%434.46%31.47%--
EPS (Basic)
--0.01-0.01-0.01-0.02-0.02-0.04-0.100.01-0.02
EPS (Diluted)
--0.01-0.01-0.01-0.02-0.02-0.04-0.100.01-0.02
Free Cash Flow Per Share
-0.00-0.01-0.01-0.01-0.01-0.01-0.01-0.07-0.030.11
EBITDA
-1.06-2.73-4.55-5.1-7-3.95-3.94-1.830.190.15
EBIT
-1.06-2.73-4.55-5.1-7-3.95-3.94-1.830.19-0.01
Showing 10 of 11 years
1 more years are available
Start Free Trial